Biosensor technology is a bioanalytical technology arising from a new interdisciplinary approach, especially with the rise of nanotechnology, by the introduction of nanomaterials applied to biosensors, the formation of biosensors combined with nanomaterials biosensors by introducing nanomaterials into biosensors, which have facilitated the generation of various functional novel biosensors. The application of biosensors in the early-stage non-invasive diagnosis of various diseases offers great potential. Also, improved in recent years by the progress made in the field of nano-biomaterials, modern biomedical sensors, through the unique characteristics of nanotechnology and nanomaterials, can more accurately detect various subtle changes in the human body, greatly improving the efficiency of disease treatment.
Although much effort has been made in the field of advanced Nanobiosensors, there are still many challenges to be addressed. The Research Topic aims to provide a platform for researchers to present their latest research findings, discuss the future development and possible challenges faced in , and promote the transformation from laboratory tests to non-invasive clinical diagnosis. This issue aims to cover the application of biosensing technology and nanotechnology in human diseases, and study the role of spectroscopy, electrochemistry and other methods combined with nanotechnology in the efficient diagnosis and treatment of these diseases.
The types of manuscripts include Original Research, Review, Mini-Review, and Perspective articles. Potential themes for this Research Topic may include, but are not limited to:
1. Spectroscopy-based detection methods, including but not limited to fluorescence, Raman, elastic scattering, evanescent waves, near/mid-infrared spectroscopy;
2. A novel, rationally designed, highly repeatable and sensitive probe that enables accurate multiplex detection;
3. Development of inexpensive and portable detection platforms, including but not limited to microfluidic chips and lateral flow methods;
4. Based on non-invasive biosensors (in vitro diagnostics) for early detection of cancer and other diseases;
5. Nanomaterials and DNA/immune-based electrochemical biosensing platforms aimed at disease diagnosis.
Biosensor technology is a bioanalytical technology arising from a new interdisciplinary approach, especially with the rise of nanotechnology, by the introduction of nanomaterials applied to biosensors, the formation of biosensors combined with nanomaterials biosensors by introducing nanomaterials into biosensors, which have facilitated the generation of various functional novel biosensors. The application of biosensors in the early-stage non-invasive diagnosis of various diseases offers great potential. Also, improved in recent years by the progress made in the field of nano-biomaterials, modern biomedical sensors, through the unique characteristics of nanotechnology and nanomaterials, can more accurately detect various subtle changes in the human body, greatly improving the efficiency of disease treatment.
Although much effort has been made in the field of advanced Nanobiosensors, there are still many challenges to be addressed. The Research Topic aims to provide a platform for researchers to present their latest research findings, discuss the future development and possible challenges faced in , and promote the transformation from laboratory tests to non-invasive clinical diagnosis. This issue aims to cover the application of biosensing technology and nanotechnology in human diseases, and study the role of spectroscopy, electrochemistry and other methods combined with nanotechnology in the efficient diagnosis and treatment of these diseases.
The types of manuscripts include Original Research, Review, Mini-Review, and Perspective articles. Potential themes for this Research Topic may include, but are not limited to:
1. Spectroscopy-based detection methods, including but not limited to fluorescence, Raman, elastic scattering, evanescent waves, near/mid-infrared spectroscopy;
2. A novel, rationally designed, highly repeatable and sensitive probe that enables accurate multiplex detection;
3. Development of inexpensive and portable detection platforms, including but not limited to microfluidic chips and lateral flow methods;
4. Based on non-invasive biosensors (in vitro diagnostics) for early detection of cancer and other diseases;
5. Nanomaterials and DNA/immune-based electrochemical biosensing platforms aimed at disease diagnosis.